Source:http://linkedlifedata.com/resource/pubmed/id/19751235
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2010-2-23
|
pubmed:abstractText |
Using a novel monoclonal anti-pan human leukocyte antigen (HLA) class I heavy chain antibody (EMR 8-5) reacting with paraffin-embedded sections, we examined the prognostic significance of HLA class I molecules in muscle-invasive bladder cancer patients who underwent radical cystectomy. Immunohistochemical staining for HLA class I molecules with monoclonal antibody EMR 8-5 was performed on specimens from 65 clinically muscle-invasive bladder cancer patients who underwent radical cystectomy and pelvic lymph node dissection without neoadjuvant chemotherapy. We analyzed the clinicopathological and prognostic significance of HLA class I expression. Immunohistochemical analysis revealed HLA class I down-regulation in 22 (33.8%) invasive bladder cancers. This down-regulation had no correlation with clinicopathological parameters such as pathologic stage, nodal status, and grade. The recurrence-free survival of patients with HLA class I-positive tumors was significantly better than that of those with down-regulation (log rank, P = 0.0337). Multivariate analysis revealed that HLA class I expression was a significant factor influencing the recurrence-free survival of bladder cancer patients after cystectomy (P = 0.0155). Our data demonstrate that HLA class I down-regulation in tumor cells was clearly observed in about one-third of the patients. HLA class I expression could be a prognostic marker for muscle-invasive bladder cancer patients after cystectomy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1349-7006
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
100
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2331-4
|
pubmed:meshHeading |
pubmed-meshheading:19751235-Adult,
pubmed-meshheading:19751235-Aged,
pubmed-meshheading:19751235-Cystectomy,
pubmed-meshheading:19751235-Down-Regulation,
pubmed-meshheading:19751235-Female,
pubmed-meshheading:19751235-Genes, MHC Class I,
pubmed-meshheading:19751235-Humans,
pubmed-meshheading:19751235-Male,
pubmed-meshheading:19751235-Middle Aged,
pubmed-meshheading:19751235-Neoplasm Invasiveness,
pubmed-meshheading:19751235-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:19751235-Urinary Bladder Neoplasms
|
pubmed:year |
2009
|
pubmed:articleTitle |
Human leukocyte antigen class I down-regulation in muscle-invasive bladder cancer: its association with clinical characteristics and survival after cystectomy.
|
pubmed:affiliation |
Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan. ichiya@sapmed.ac.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|